4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-005213
Vice Pres Sales & Marketing gave up 593 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bitterman Chris T. Vice Pres Sales & Marketing | 2024-03-23 | Shares withheld for taxes | −593 | $1.81 | $1,073 | 4,683 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bitterman Chris T. Vice Pres Sales & Marketing | 2024-03-25 | Grant or award · Options (right to buy) | +2,750 | $1.71 | $4,703 | 13,250 | D: show line 2 in the form |
Loading xslF345X05/marketforms-65387.xml…